This year’s edition will explore how the alignment between HTA and regulatory can contribute to more efficient decision-making, with attention to the new pharmaceutical legislation and HTA regulations, and will provide an opportunity to connect with people from the regulatory science network in the Netherlands. Registration and the preliminary agenda will follow soon.